How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study

How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study

Abstract Background Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most severely hypoxemic, acute respiratory distress syndrome (ARDS) patients. However, the recommended dosage as well as the necessity of monitoring the neuromuscular block is unknown. We aimed to...

Full description

Bibliographic Details
Main Authors: Sami Hraiech, Jean-Marie Forel, Christophe Guervilly, Romain Rambaud, Samuel Lehingue, Mélanie Adda, Pierre Sylla, Sabine Valera, Julien Carvelli, Marc Gainnier, Laurent Papazian, Jérémy Bourenne
Format: Article
Language:English
Published: SpringerOpen 2017-08-01
Series:Annals of Intensive Care
Subjects:
ARDS
Neuromuscular blockers
Cisatracurium
Train-of-four
Cost
Online Access:http://link.springer.com/article/10.1186/s13613-017-0305-2

Internet

http://link.springer.com/article/10.1186/s13613-017-0305-2

Similar Items